Engineered Binding Proteins that Specifically Target Bacteria
Invention type: Technology
/
Case number: #22368
Described herein are antigen-binding molecules that bind to bacteria (e.g., Listeria monocytogenes) and methods of use thereof. Also described herein are compositions and kits comprising these antigen-binding molecules.
Researchers
Hadley Sikes
/
Yining Hao
/
Ki-Joo Sung
Departments: Department of Chemical Engineering
Technology Areas: Biotechnology: Biomanufacturing, DNA & RNA Editing, Synthetic Biology / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
engineered binding proteins for recognition of bacteria
United States of America | Published application -
engineered binding proteins for recognition of bacteria
Singapore | Pending -
engineered binding proteins for recognition of bacteria
Japan | Published application -
engineered binding proteins for recognition of bacteria
Mexico | Published application -
engineered binding proteins for recognition of bacteria
European Patent Convention | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.